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Abstract 
Objective: Depression is common in people with long term conditions, and is associated 
with worse medical outcomes. Previous research shows perseverative negative thinking 
(e.g. worry, rumination) predicts subsequent depression and worse medical outcomes, 
suggesting interventions targeting perseverative negative thinking could improve 
depression and medical outcomes. Previous studies recruited healthy individuals, however. 
This review aimed to determine the temporal relationship and strength of prospective 
association of perseverative negative thinking with depression, anxiety and emotional 
distress in people with long term conditions. 
Method: Four electronic databases were searched for studies including standardised 
measures of perseverative negative thinking and depression, anxiety or emotional distress, 
and which presented prospective associations. Findings were narratively synthesized. 
Results: Thirty studies were identified in a range of long term conditions. Perseverative 
negative thinking and subsequent depression, anxiety or emotional distress were 
significantly correlated in the majority of studies (bivariate r=0.23 to r=0.73). 25 studies 
controlled for confounders, and in 15 perseverative negative thinking predicted subsequent 
depression, anxiety or emotional distress. Results varied according to condition and study 
quality. Six of 7 studies found bivariate associations between depression, anxiety or 
emotional distress and subsequent perseverative negative thinking, though 2 studies 
controlling for key covariates found no association. Few studies assessed the impact of 
perseverative negative thinking on medical outcomes. 
Conclusion: Strongest evidence supported perseverative negative thinking predicting 
subsequent depression, anxiety and emotional distress in people with long term conditions. 
Further prospective research is warranted to clarify the association of perseverative 
negative thinking with subsequent poor medical outcomes. 
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• Perseverative negative thinking correlated with outcomes (r=0.23 to r=0.73). 
• 25 studies controlled for confounders, and an association was found in 15 of those. 
• Findings varied according to long term condition and study quality. 
• Perseverative negative thinking may be a target for treatment of depression in LTCs. 
 
Introduction  
Chronic physical illnesses (i.e. long term conditions – LTCs) are conditions that 
cannot currently be cured but can be managed with treatment e.g. asthma, diabetes, 
coronary heart disease. It is estimated that 15 million people in England have a LTC, and 
people with LTCs account for 70% of all health and care spending[1].  
Depression is common in people with chronic physical illnesses[2, 3] and is 
associated with worse medical outcomes such as increased morbidity and mortality[4-7], 
worse health-related quality of life[8-10], and increased healthcare utilisation[11, 12]. 
Understanding the factors contributing to the development of depression among people 
with LTCs could therefore: i) help identify who is at increased risk of developing depression 
and worse medical outcomes, ii) facilitate the stratification and personalisation of 
psychological and/or medical management and iii) lead to the development of novel 
interventions that might improve both depression and other health outcomes. Biological, 
psychological and social risk factors for depression have been identified among people with 
long term conditions [13-17], though findings from previous research are often mixed and 
contradictory. Furthermore, many of the risk factors identified are inter-related and the 
most important factors predicting (and potentially causing) depression in people with LTCs 
remain unclear[18].  
Perseverative negative thinking is a term used to describe processes such as worry 
and rumination, in which individuals experience repetitive, prolonged and recurrent 
negative thoughts about themselves, their symptoms, their problems, or their  
concerns[19].  Perseverative negative thinking predicts negative affect [20-25], including the 
onset, maintenance and relapse of depression (e.g.[26-40]). Such thinking also predicts 
adverse medical outcomes, such as poor cardiovascular health, impaired wound healing and 
immune dysfunction[41-43]. These findings suggest that perseverative negative thinking 
could be a potential target for interventions aimed at improving both medical and 
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psychological outcomes. Most previous prospective research into perseverative negative 
thinking has focussed on physically healthy populations, however. The characteristics of 
perseverative negative thinking and the nature of its associations with psychological 
outcomes among people with LTCs are not clear. 
The aims of this systematic review are to clarify the temporal relationship and the 
strength of association between perseverative negative thinking and depression, anxiety 
and emotional distress among people with LTCs.  
 
Method 
This review was conducted following the guidance of the University of York Centre 
for Reviews and Dissemination[44] and is reported in accordance with the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses statement[45]. The review 
protocol was previously published[46]. 
 
Inclusion/exclusion criteria 
Studies were included if they investigated among people with LTCs the prospective 
association between perseverative negative thinking, on the one hand, and depression, 
anxiety and emotional distress, on the other. Since we were interested in clarifying the 
temporal relationship, studies examining the prospective association between perseverative 
negative thinking and subsequent depression, anxiety or emotional distress, or the reverse 
association, i.e. depression, anxiety or emotional distress predicting perseverative negative 
thinking, were included. 
Perseverative negative thinking was defined as repetitive, prolonged and recurrent 
negative thoughts about oneself and one’s concerns (including worry, rumination, 
perseverative cognition, counterfactual thinking, mind wandering, post-event processing, 
habitual negative self-thinking and catastrophizing [20, 47, 48]). We did not include 
measures of constructive repetitive thought such as reflection, rehearsal, planning, and 
problem solving. Depression, anxiety and emotional distress was used to refer to symptoms 
of mood disorders and negative emotional states including negative mood. We defined LTCs 
broadly, as conditions which cannot be cured but which can be managed with treatment[1].  
Studies meeting the following criteria were included: 
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Population Studies in adults (>16 years) with any LTC.  
Interventions & Comparators Use of an intervention and comparator was not a 
requirement.  
Outcomes Studies including a standardised measure of perseverative negative 
thinking and a standardised measure ofdepression, anxiety or emotional distress (including 
negative mood and negative affect). Data were extracted on physical outcomes as well 
asdepression, anxiety or emotional distress, where available. 
Study design Observational, prospective studies, and experimental or quasi-
experimental studies. We anticipated that findings from such studies would clarify temporal 
relationships between perseverative negative thinking anddepression, anxiety or emotional 
distress, enabling tentative causal inferences to be drawn. Cross-sectional and other study 
designs that would not allow such inferences were excluded. 
Other limiters No date or language restrictions were applied. Studies published as 
papers in peer reviewed journals, conference proceedings and dissertations were included.  
 
Information sources and search strategy 
MEDLINE, EMBASE, PsycINFO, and CINAHL databases were searched on 4th June 
2013, and searches repeated on 19th June 2015 and 7th Sept 2016. Search terms included 
subject headings and free text words relevant to: (1) depression, anxiety, emotional and 
psychological distress, (2) perseverative negative thinking, and (3) prospective study design 
(see Appendix A for search strategy). As there is no comprehensive and definitive list of LTCs 
available, we did not search for studies of people with LTCs using electronic search terms; 
suitable studies of people with LTCs were identified by hand-searching papers meeting 
criteria 1-3 above, to maximise sensitivity of our search strategy. Backward and forward 
citation searches of eligible studies were undertaken, and authors of included studies were 
contacted to identify any additional unpublished studies.  
 
Study selection1 
                                                          
1
 Supplementary information regarding study selection, data extraction and quality assessment is available in 
Appendix B. 
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Eligibility screening of titles and abstracts, and then of full text records, was 
completed independently by two reviewers. Agreement between reviewers was 80% at 
title/abstract screening stage, and 94% at full text screening. Disagreements were resolved 
by discussion, with the involvement of a third reviewer where agreement could not be 
reached. Findings from single, independent studies presented in multiple 
reports/publications were presented only once, to avoid double counting studies. 
 
Data extraction 
Data from included studies was extracted independently by two reviewers and 
included characteristics of the study (design, participants, measures, timing of assessments, 
physical health/medical outcomes included, statistical methods) and the study findings 
(covariates controlled, strength of association). Agreement between reviewers for the 
primary outcome of bivariate associations was 93%, with disagreements resolved by 
discussion. Authors were contacted for further data in cases where suitable measures were 
taken but outcomes of interest were not presented in the published papers. 
 
Risk of bias 
Risk of bias within each study was independently evaluated by two reviewers using 
the Effective Public Health Practice Project (EPHPP) Quality Assessment Tool[49]. Ratings 
were made for six components (selection bias, study design, confounders, blinding, data 
collection methods, and withdrawals). Each component was rated strong, moderate or 
weak, and additionally these ratings were combined into a global quality score, such that 
globally strong studies had at least 4 strong and no weak ratings, moderate studies had 1 
weak rating, and weak studies had more than 1 weak rating. Minor adaptions to the 
confounders and blinding components of the EPHPP tool were necessary due to the design 
of the included studies. Agreement between reviewers for global quality ratings was 73%, 
with disagreements resolved by discussion. 
 
Data synthesis 
Characteristics and findings of included studies are summarised in tables. Findings 
are  narratively synthesized (informed by the guidelines of the ESRC methods 
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programme[50] where possible) based on grouping studies according to: i) type of 
perseverative negative thinking measured, ii) type of psychological outcome measured (i.e. 
depression, anxiety or emotional distress), iii) timing of follow-up (6 months or less versus 
more than 6 months), iv) type of  LTC, and v) type of analysis conducted (bivariate versus 
multivariable). 
 
Results 
Study selection 
Details of study selection are shown in Figure 1. Thirty eligible studies were included 
in the review [51-82]. Authors of a further 46 potentially eligible studies were contacted for 
additional data; authors of 15 studies were unable to provide additional data, and authors 
of 31 did not respond. It was not possible to contact authors of a further 2 studies for 
additional information and these studies were therefore excluded. 
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Figure 1: PRISMA flowchart
9042 records identified by 
database searches 
4783 records after 
duplicates removed 
4783 records title and 
abstract screened 
264 full-text records 
assessed for eligibility 
25 records (24 studies) for 
inclusion 
30 studies included in 
narrative synthesis 
7 additional records 
(6 studies) identified 
through other 
sources 
239 full-text records excluded 
 
132 = no LTC 
48 = no measure of PNT 
1 = no measure of depression, 
anxiety or distress 
8 = not prospective design1 = 
review paper 
1 = protocol paper 
48 = unclear if data prospective, or 
prospective data not reported, and 
authors could not provide more 
information/could not be 
contacted 
 
4519 records excluded 
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Study characteristics 
There were 26 observational cohort studies, 3 prospective evaluations of an 
intervention, and 1 randomised controlled trial. Characteristics of all included studies are 
given in Table 1. 
Samples Sample sizes ranged between n=22 to n=560 in relevant prospective 
analyses (median n=99). Mean age ranged between 24.3 to 70.1 years, with subjects ranging 
from 0% to 100% female.  
There were 5 studies in people with vascular disease [52, 54, 55, 57, 73, 76]), 4 in 
rheumatoid arthritis[63, 69-71], 10 in cancer[51, 53, 56, 58, 66, 67, 74, 75, 78, 81], 2 in 
individuals experiencing infertility[64, 65], 2 in muscular dystrophy or cerebral palsy[61, 68], 
and 7 in chronic pain-related conditions[60, 62, 72, 77, 79, 80, 82].  
Measures Included studies measured five types of perseverative negative thinking 
(rumination, catastrophizing, worry, anxious pre-occupation and preoccupation with death) 
using a total of 15 different measures. Six types of psychological outcome were identified 
(depression, anxiety, psychological distress, psychological functioning, negative affect and 
negative mood) measured using 15 different scales.  
Timing of assessments Duration of LTC at baseline assessment was up to 1 month in 
6 studies, up to 1 year in 3 studies, more than one year in 12 studies (maximum 16.5 years), 
and unclear in 9 studies. Median duration of LTC was 12.6 months. In 16 studies there was 
one follow-up assessment, in 12 studies there were between 2 and 5 follow-ups, and in 2 
studies follow-ups took the form of daily diary measures completed over 14 – 30 days. The 
median number of follow-up assessments was 1. Follow-up assessments took place within 1 
month (8 studies), between 1 and 6 months (17 studies), 6 months to 1 year (11 studies), 
and 1 to 2 years (5 studies). The median time to follow-up was 6 months. 
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Table 1: Characteristics of included studies 
ID Authors and date Condition Sample size Mean 
age  
Males 
(%)b 
Sample Assessments PNT measure Anxiety, depression or mood 
measure 
   Recruited Analyseda (years)b      
1 Denton et al. (2012, 2011) Acute 
coronary 
syndrome 
457 387 61.1 58.6 Eligible patients on coronary care 
and cardiac step-down units of 
three hospitals; USA 
T1=within 1 week of 
index event, T2=3 
months post-ACS 
Ruminative responses scale 
of the Response Styles 
Questionnaire @ T1 and T2 
Beck Depression Inventory 
@ T1 and T2 
2 Garnefski & Kraaij (2010) Myocardial 
infarction 
160 88 56.0 80.7 Patients aged <70 years from 
cardiology outpatient clinic 
database who had received PCI in 
the previous 3-12 months; 
Netherlands 
T1=within 3-12 
months following PCI, 
T2=12 months later 
Rumination and 
catastrophizing subscales of 
the Cognitive Emotion 
Regulation Questionnaire @ 
T1 
Hospital Anxiety & 
Depression Scale @ T1 and 
T2 (depression subscale) 
3 Vogele et al. (2012) Myocardial 
infarction 
36 24c 57.6 89 Patients with acute first MI 
contacted in hospital; Germany 
T1=5-15 days post-MI, 
T2=6-8 weeks post-MI, 
T3=6 months post-MI 
Rumination subscale of the 
Trierer Skalen zur 
Krankheitbewaltigung 
(Coping questionnaire) @ T1 
Centre for Epidemiologic 
Studies Depression Scale @ 
T1, T2, and T3 
4 Baker (2014) Coronary 
heart disease 
101 85 66 – 75 
modal 
range 
76.2 Inpatients or outpatients 
presenting for cardiac care at 
hospital; UK 
T1=after attendance 
at inpatient or 
outpatient cardiology 
service, T2=3 months 
later 
Ruminative Responses Scale  
of the Response Styles 
Questionnaire @ T1 and T2 
Patient Health 
Questionnaire-9 (depression) 
@ T1 and T2 
5 Xiao et al. (2011) Hypertension 650 560 55.4 51.8 Randomly selected  from 1200 
hypertension patients at one 
hospital; China 
T1=following at least 1 
year of hypertension, 
T2=6 months later 
Rumination and 
catastrophizing subscales of 
the Cognitive Emotion 
Regulation Questionnaire @ 
T1 
Centre for Epidemiologic 
Studies Depression Scale @ 
T1 and T2 
6 Keefe et al. (1989) Rheumatoid 
arthritis 
Unclear 223 52.7 25 Patients identified by rheumatology 
practices; USA 
T1=within 7 years of 
diagnosis, T2=6 
months later 
Catastrophizing subscale of 
the Coping Strategies 
Questionnaire @ T1 and T2 
Centre for Epidemiologic 
Studies Depression Scale @ 
T1 and T2 
7 Sturgeon & Zautra (2013) Rheumatoid 
arthritis 
231 93% diary 
completion 
55.0 30.4 Patients invited to participate at 
health fairs, Arthritis Foundation 
members, local physicians offices, 
Veterans Administration Hospital; 
USA 
Daily diary for 30 days 
(once per day), 
starting an average of 
13.6 years post-
diagnosis 
2 items from the 
catastrophizing subscale of 
the Coping Strategies 
Questionnaire @ daily 
Positive and Negative Affect 
Schedule; depressive 
symptoms @ daily  
8 Schiaffano & Revenson (1995) Rheumatoid 
arthritis 
101 64 NR 20 Eligible patients from hospital  
outpatient clinic, or from 
rheumatology practices; USA 
T1=within 2 years of 
diagnosis, T2=18 
months later 
5-point Likert scale of 
rumination @ T2 
Centre for Epidemiologic 
Studies Depression Scale @ 
T1 and T2 
9 Sharpe et al. (2001) Rheumatoid 53 22 55.1 30 Consecutive patients at T1=within 2 years of Catastrophizing subscale of Hospital Anxiety & 
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arthritis  rheumatology clinics of three 
general hospitals, enrolled into 
RCT; UK 
diagnosis,T2=3 
months , T3=6 
months, T4=9 months, 
T5=15 months, T6=21 
months later 
the Coping Strategies 
Questionnaire @ T1, T2, T3, 
T4, T5 and T6 
Depression Scale @ T1, T2, 
T3, T4, T5 and T6 
10 Wang et al. (2014) Breast cancer 509 504 48.3 0 Eligible women who had 
undergone surgery for breast 
cancer at two hospitals; China 
T1=approx. 1 week 
post-diagnosis (5-7 
days post-surgery), 
T2=1 month later 
Rumination and 
catastrophizing subscales of 
the Cognitive Emotion 
Regulation Questionnaire @ 
T1 
Centre for Epidemiologic 
Studies Depression Scale @ 
T1 and T2 
11 Andreu et al. (2012) Breast cancer 174d 102 50.5 0 Consecutive patients attending pre-
operative visit at department of 
surgery at oncology clinic; Spain 
T1=pre-surgery (at 
preliminary diagnosis), 
T2=2-7 days post-
surgery, T3=at 
definitive diagnosis, 
T4=at chemotherapy 
Anxious preoccupation 
subscale of the Mental 
Adjustment to Cancer Scale 
@ T4 
Brief Symptom Inventory 18 
(distress)  @ T1, T2, T3 and 
T4 
12 Ferrero et al. (1994) Breast cancer 68 66 53.0 0 Consecutive newly diagnosed 
patients attending hospital 
oncology clinic; Spain 
T1=after diagnosis 
(approx. 1 month 
post-surgery), T2=4 
months post-surgery, 
T3=7 months post-
surgery   
Anxious preoccupation 
subscale of the Mental 
Adjustment to Cancer Scale 
@ T1, T2 and T3 
Breast Cancer Quality of Life 
Questionnaire (psychological 
distress subscale) @ T1, T2 
and T3 
13 Groarke et al. (2013) Breast cancer 355 221 24.3 0 Consecutive eligible patients 
attending a breast symptomatic 
unit at a University-affiliated 
hospital; Ireland 
T1=within 1 week of 
diagnosis, T2=4 
months later 
Anxious preoccupation 
subscale of the Mental 
Adjustment to Cancer Scale 
@ T1 and T2 
Hospital Anxiety & 
Depression Scale; Positive 
and Negative Affect 
Schedule @ T1 and T2 
14 Lam et al. (2013) Advanced 
breast cancer 
228 192 53.5 0 Hospital outpatients identified 
from clinic lists of 6 
breast/oncology clinics; China 
T1=post- diagnosis 
(awaiting or receiving 
initial chemotherapy), 
T2=6 weeks, T3=3 
months, T4=6 months, 
T5=12 months later 
Cancer-related Rumination 
Scale @T1  
Hospital Anxiety & 
Depression Scale @ T1, T2 
and T5 
15 Thomsen et al. (2013) Colon cancer 67 54 63.5 54 Patients referred for chemotherapy 
at hospital oncology department; 
Denmark 
T1=1-7 months post-
diagnosis (mean 72 
days), T2=8 months 
later 
Rumination-Reflection 
Questionnaire @ T1 and T2 
Beck Depression Inventory 
@ T1 and T2 
16 Couper et al. (2010) Early and 
advanced  
prostate 
367 (211 
early; 156 
advanced) 
265 (178 
early; 87 
advanced) 
66.2 
early; 
70.1 
100 Consecutive patients recruited by 
their oncologist/urologist from 
public hospitals and practices; 
T1=after diagnosis, at 
beginning treatment 
(early) or after 
Anxious preoccupation 
subscale of the Mental 
Adjustment to Cancer Scale 
Brief Symptom Inventory 53 
(anxiety and depression) @ 
T1 and T2 
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cancer advanced Australia patients informed 
disease metastatic 
(advanced), T2=12 
months later 
@ T1 and T2 
17 Lehto & Cimprich (2009) Suspected 
lung cancer 
52 42 64.0 64.3 Patients undergoing surgical 
evaluation for lung cancer at a 
comprehensive cancer center; USA 
T1=at diagnosis (14 
days prior to surgery), 
T2=5-6 weeks later 
Penn State Worry 
Questionnaire @ T1 and T2 
State-Trait Anxiety Inventory 
@ T1 and T2 
18 Lampic et al. (1994) Mixed cancer 197 121 61.0 37 Consecutive patients scheduled for 
hospital appointment at oncology 
clinic; Sweden  
T1=at clinic 
appointment (median 
6 yrs from diagnosis), 
T2=few days after 
appointment, T3=3 
weeks after 
appointment 
Anxious preoccupation 
subscale of the Mental 
Adjustment to Cancer Scale 
@ T2; Cancer-related worry 
@ T1, T2, and T3 
Visual analogue ratings of 
anxiety @ T1, T2 and T3 
19 Vollmer et al. (2011) Haematologic 
malignancy 
102e 45 
 
46.7 51.6 Consecutively enrolled patients 
with haematologic malignancies 
identified from weekly lists of 
inpatients; Germany 
T1=within 7 days post-
admission, T2=at least 
4 weeks later 
Preoccupation with death 
subscale of the Subjective 
Assessment of the Course of 
Disease & Death @ T1 and 
T2 
Hospital Anxiety & 
Depression Scale @ T1 and 
T2 
20 Kraaij et al. (2008) Definitive 
infertility 
169 99 
 
41.0 38 
 
Individuals with definitive infertility 
responding to announcements in 
local media and online self-help 
groups; Netherlands 
T1=average 5 years 
post-diagnosis, T2=2 
years later 
Rumination and 
catastrophizing subscales of 
the Cognitive Emotion 
Regulation Questionnaire @ 
T1 and T2 
Depression subscale of the 
Symptom Check List @ T1 
and T2 
21 Kraaij et al. (2010) Infertility 313 139 35.0 22 Patients who had attended an 
infertility clinic for treatment within 
the previous 4 months; 
Netherlands 
T1=within 4 months of 
most recent 
treatment, T2=9 
months later 
Rumination and 
catastrophizing subscales of 
the Cognitive Emotion 
Regulation Questionnaire @ 
T1 
Hospital Anxiety & 
Depression Scale @ T1 and 
T2 
22 Nieto et al. (2012) Muscular 
dystrophy 
395f 107 50.2 43 Participants identified from 
National Registry of Myotonic 
Dystrophy & Facioscapulohumeral 
Muscular Dystrophy Patients & 
Family Members, and from 
neuromuscular disease clinic; USA 
T1=average 16.5 years 
post-diagnosis, T2=24 
months later 
Catastrophizing subscale of 
the Coping Strategies 
Questionnaire @ T1; Pain 
Catastrophizing Scale @ T2  
5 item SF-36 mental health 
scale (psychological 
functioning) @ T1 and T2 
23 Jensen et al. (2006) Cerebral 
palsy 
48 48 40.1 50 Patients who participated in a 
previous cross-sectional study; USA 
T1=after previous 
study (pain duration 
≥3 months) , T2=6 
months later 
Catastrophizing subscale of 
the Coping Strategies 
Questionnaire @ T1 and T2 
Centre for Epidemiologic 
Studies Depression Scale @ 
T1 and T2 
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24 Turner et al. (2004) Tempromand
ibular 
disorder 
110 100 38.8 13 Patients evaluated at a TMD clinic 
and enrolled in a RCT; USA 
T1= prior to 
enrolment in RCT, 
where facial pain ≥3 
months, T2= daily 
diary for next 14 days 
(3 times per day)  
Catastrophizing subscale of 
the Coping Strategies 
Questionnaire @ T1; brief 
daily diary measure of 
catastrophizing/rumination 
(3 Likert-style items) @ T2 
Beck Depression Inventory 
@ T1; brief daily diary 
measure of negative mood 
(‘unhappy’, ‘annoyed’, 
‘anxious’) @ T2 
25 Hanley et al. (2004), Jensen et 
al. (2002) 
Phantom limb 
pain 
89 70g 44.7 73 Consecutive admissions at 
Department of Orthopaedic 
Surgery for lower limb amputation 
invited to participate in RCT; USA 
T1=1 month post-
amputation, T2=6 
months post-
amputation, T3=12 
months post-
amputation, T4=24 
months post-
amputation 
Catastrophizing subscale of 
the Coping Strategies 
Questionnaire @ T1, T2, T3 
and T4 
Centre for Epidemiologic 
Studies Depression Scale @ 
T1, T2, T3 and T4 
26 Jensen et al. (2001) Chronic pain 
(mixed 
primary sites) 
197 141 44.7 49 Patients enrolled in 
multidisciplinary pain management 
program; USA 
T1=pre-treatment 
(mean pain duration 
3.2 years), T2=post-
treatment (approx. 3 
weeks later), T3=6 
months later, T4=12 
months later  
Catastrophizing subscale of 
the Coping Strategies 
Questionnaire @ T1, T2, T3 
and T4 
Centre for Epidemiologic 
Studies Depression Scale @ 
T1, T2, T3 and T4 
27 Sparkes et al. (2015) Mixed pain 
conditions 
75 56 47.4 44.6 Consecutive patients assessed by a 
multidisciplinary team at a 
secondary care centre and referred 
for a spinal cord stimulation (SCS) 
trial; UK 
T1= 1 week before 
SCS trial (mean pain 
duration 8.2 years), 
T2=6 months post-
SCS, T3=12 months 
post-SCS 
Catastrophizing subscale of 
the Coping Strategies 
Questionnaire @ T1, T2, T3 
Hospital Anxiety & 
Depression Scale @ T1, T2, 
T3 
28 Mehlsen et al. (2015) Chronic pain  87 73 52 15 Patients Invited to attend a pain 
self-management course by local 
health care and social work 
professionals (pain duration >3 
months); Denmark 
T1= 2-14 days before 
course; T2=1-3 weeks 
after course, T3=5-6 
months after course  
Pain Catastrophizing Scale @ 
T1, T2, T3 
Depression and anxiety 
subscales of the Common 
Mental Disorders 
Questionnaire @ T1, T2, T3 
29 Bourgault et al. (2015) Fibromyalgia 
syndrome 
58 37 50 7.1 Patients  recruited via newspaper 
adverts for a fibromyalgia self-
management intervention (mean 
duration of pain >10 years); Canada 
T1=prior to 
intervention, T2=post-
intervention (~11 
weeks), T3=3 months, 
T4=6 months, T5=12 
months later 
Catastrophizing subscale of 
the Coping Strategies 
Questionnaire @ T1, T2, T3, 
T4, T5 
Beck Depression Inventory 
@ T1, T2, T3, T4, T5 
30 Rzewuska et al. (2015) Musculo- 502 502h 64.8 38.6 Consecutive older adults presenting T1=following GP Catastrophizing subscale of Hospital Anxiety & 
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skeletal pain with musculoskeletal pain in five 
general practices; UK 
consultation, T2=3 
months, T3=6 months, 
T4=12 months 
the Coping Strategies 
Questionnaire @ T1, T2, T3, 
T4 
Depression Scale @ T1, T2, 
T3, T4 
aWhere more than one follow-up, ‘N analysed’ refers to N included in appropriate analyses at final time point 
bDemographics (age and sex) of whole sample at baseline  
cRefers to Pearsons correlations, for partial correlations n=17 
d126 met inclusion criteria  
eDoes not include 33 controls who participated at T1 but were not required to participate at T2  
f279 met inclusion criteria 
g61 at T2 
h392 completers at T4, but all cases who completed at least one assessment were included in analyses 
Abbreviations: PNT = perseverative negative thinking, PCI = percutaneous coronary intervention, MI=myocardial infarction, T1 = time 1 (baseline), T2 = time 2 (follow-up), T3 = time 3 (follow-up), T4 = time 4 (follow-
up), T5 = time 5 (follow-up), T6 = time 6 (follow-up) 
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Perseverative negative thinking and negative affect 
Findings from all included studies are summarised in Table 2.  
Bivariate analyses Prospective, bivariate correlations between perseverative 
negative thinking and subsequent depression, anxiety or emotional distress were reported 
in 20 of the 30 studies identified.  The most commonly studied associations were of 
rumination (7 studies) and catastrophizing (9 studies) with depression. Eighteen studies 
found a significant association between perseverative negative thinking at one assessment 
time with depression, anxiety or emotional distress at a subsequent time. One of these 
studies[56] found mixed evidence of an association (3 out of 4 correlations significant). The 
2 studies that did not find a significant association had particularly low sample sizes at 
follow-up (n=24[73] and n=22[70]). Bivariate effect sizes ranged between r=.23 and r=.73, 
representing small to moderate effects. 
The significant associations did not appear to be influenced by type/measure of 
perseverative negative thinking, type/measure of depression, anxiety or emotional distress, 
or whether follow-ups took place at less than or greater than 6 months (median time to 
follow-up) after baseline. 
Reverse-associations 7 of the 30 identified studies reported bivariate correlations 
between baseline depression, anxiety or emotional distress with subsequent perseverative 
negative thinking, and 6 of these found a significant positive association.  
Multivariable analyses Multivariable analyses of the association between 
perseverative negative thinking with subsequent depression, anxiety or emotional distress 
were available for 25 of the 30 included studies and included partial correlations (4 studies), 
multiple regression (19 studies), and latent growth models combined with logistic regression 
to predict trajectories of depression and anxiety (2 studies). Consistent with bivariate 
analyses the most commonly studied associations were of rumination with depression (8 
studies) and catastrophizing with depression (10 studies). 
Age, sex and baseline depression (or anxiety, as appropriate) were the variables 
most commonly controlled for (15, 14 and 17 studies, respectively). Only 8 studies 
controlled for all three of these confounders (and 2 studies in entirely female samples 
controlled for both age and baseline depression). A variety of other demographic, disease, 
physical and psychosocial factors were also controlled for.  
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Ten studies found significant positive associations between measures of 
perseverative negative thinking and subsequent depression, anxiety or emotional distress, 
and a further 5 showed mixed results, i.e. some associations significant but some not. Five 
of these studies controlled for age, sex and baseline depression, and 3 studies controlled for 
baseline depression alone. One study found a negative association, i.e. where high 
catastrophization at baseline predicted greater improvement in depression over the 
subsequent period. 
Significant multivariable associations were found more often in studies that 
measured the effect of catastrophizing on subsequent depression, anxiety or emotional 
distress compared to studies that measured the effect of rumination. However, associations 
did not appear to be influenced by the measure of depression, anxiety or emotional distress 
used. In addition, associations did not vary according to whether follow-ups took place 
before or after the median time to follow-up (6 months), although significant effects were 
found less often in studies with particularly short (up to 1 month) and long (>1 year) follow-
ups and most frequently among studies with follow-up periods between 1 month and 1 year 
(although there were fewer studies with particularly short or long follow-ups). 
A variety of effect sizes and coefficients were reported. Partial correlations ranged 
from r=.23 to r=.35. For multiple regression analyses, the contribution of perseverative 
negative thinking to subsequent depression, anxiety or emotional distress was indicated 
using ΔR2 (range=.01 to .083), β (range=.21 to .53), or B (range=.0865 to .62). Odds ratios 
(range=1.15 to 8.75) were given for logistic regression analyses. In studies that controlled 
for baseline depression, anxiety or emotional distress, the range of partial correlations, ΔR2 
and odds ratios were unchanged, however the range of B was higher (range=.61 to .62; but 
based on only 2 observations) and β was available for only one study with a value of .21.  
Reverse-associations Only 2 studies reported multivariable analyses (multiple 
regression in both cases) of the association of depression, anxiety or emotional distress with 
subsequent perseverative negative thinking, and neither found a significant association.  
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Table 2: Findings of included studies 
ID Authors and date 
 
Bivariate findings Multivariable findings Variables controlled for 
1 Denton et al. (2012; 2011) T1 rumination correlates with T2 depression (r=.49, 
p<.001); T1 depression correlates with T2 rumination 
(r=.52, p<.001) 
T1 rumination predicts T2 depression independently (ΔR2=.01, ΔF=9.21, p=.003) and in 
interaction with poor dyadic adjustment (ΔR2=.01, ΔF=2.67, p=.03) 
In patients depressed at baseline T1 rumination independently predicts T2 depression (ΔR2 = 
0.03, ΔF=6.65, p=0.01) 
In patients non-depressed at baseline T1 rumination does not independently predict T2 
depression (ΔR2=.002, ΔF=.80, p=.37), but T1 rumination predicts T2 depression in interaction 
with poor dyadic adjustment (ΔR2=.06, ΔF=5.31, p<0.001) 
Age, sex, partner, years of schooling, 
work status, ethnicity, baseline 
depression, Charlson comorbidity 
index, cardiac disease severity 
2 Garnefski & Kraaij (2010) T1 rumination correlates with T2 depression (r=.43, 
p<.001); T1 catastrophizing correlates with T2 depression 
(r=.45, p<.001) 
T1 rumination/catastrophizing predicts T2 depression (β=.35, p<.001) Sex, age, physical limitations 
3 Vogele et al. (2012) T1 rumination does not correlate with depression at T2 
(r=.01, ns) or T3 (r=.14, ns) 
T1 rumination does not correlate with depression at T2 (r=.10, ns)  or T3 (r=.24, ns) Baseline depression 
4 Baker (2014) T1 rumination correlates with T2 depression (r=.73, 
p=.01); T1 depression correlates with T2 rumination 
(r=.70, p=.01) 
T1 rumination predicts T2 depression (β=.46, B=.202, SE=.043, t=4.705, p<.001, R2=.083) Baseline depression, cardiac quality 
of life, age, sex, body mass index, 
social support 
5 Xiao et al. (2011) Greater rumination at T1 correlates with greater 
depression at T2 (r=.38, p<.001); greater catastrophizing 
at T1 correlates with greater depression at T2 (r=.37, 
p<.001) 
Higher T1 rumination (B=.62, t=0.18, p<.001) and T1 catastrophizing (B=.61, t=.18, p<.001) 
predicts increases in T2 depressive symptoms  
Sex, baseline depression, smoking, 
alcohol use, coffee consumption 
6 Keefe et al. (1989) T1 catastrophizing correlates with T2 depression (r=.62, 
p<.01) 
T1 catastrophizing predicts T2 depression (sr2=.043, F=20.87, p=<.001) Baseline depression, age, SES, sex, 
disability support status, duration of 
disease 
7 Sturgeon & Zautra (2013) Bivariate analyses not reported Previous day catastrophizing predicts subsequent day depressive symptoms (B=.0865, p<.05) but 
not negative affect (B=.0016, ns) 
Age, sex, neuroticism, positive affect 
(negative affect analysis only) 
8 Schiaffano & Revenson (1995) T1 depression correlates with T2 rumination (r=.30, 
p<.05) 
T1 depression does not predict T2 rumination (β=.22, ΔR2=.05, F=2.84, p<.10) Education 
9 Sharpe et al. (2001)b T1 catastrophizing does not correlate with T2 
depression(r=.18, p=.461), T6 depression (r=.03, p=.891), 
T2 anxiety (r=.32, p=.177) or T6 anxiety (r=.12, p=.607) 
T1 catastrophizing does not correlate with T2 depression (r=.11, p=.671) or anxiety (r=.34, p=.17) Age, baseline depression, baseline 
anxiety 
10 Wang et al. (2014) Bivariate analyses not reported T1 rumination (β=.09, SE=0.12, ns) and catastrophizing (β=.26, SE=.15, ns) do not predict T2 
depression 
Age, place of residence, marital 
status, years of schooling, 
employment status, disease severity, 
baseline depression 
11 Andreu et al. (2012) T4 anxious preoccupation does not correlate with T1 (-
.08, ns), T2 (-.04, ns) or T3 (.02, ns) distress 
Multivariable analyses not reported None 
12 Ferrero et al. (1994) T1 anxious preoccupation does not correlate with T2 
distress (r=.21, ns) but does correlate with T3 distress 
(r=.40, p<.001); T2 anxious preoccupation correlates with 
T1 anxious preoccupation does not predict T2 or T3 distress (relevant regression statistics not 
reported) 
T2 anxious preoccupation predicts T3 distress (full model R2=.428, p<.001, including predictors 
Baseline distress, physical symptoms 
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T3 distress (r=.32, p<.01) MAC ‘fighting spirit’, ‘fatalism’, and ‘denial’ , and T1 psychological distress and physical 
symptoms) 
13 Groarke et al. (2013)b T1 anxious preoccupation correlates with T2 depression 
(r=.23, p <.001) and T2 anxiety (r=.35, <.001) 
T1 anxious preoccupation does not predict T2 depression (β=.014, B=.010, SE(B)=.048, t=.216, 
ΔR2 =.000, ΔF=.046, p=.830), T2 anxiety (β=.038, B=.036, SE(B)=.058, t=.617,  ΔR2 =.001, ΔF=.381, 
p=.538) or T2 negative affect (β=.022, B=.041, SE(B)=.121, t=.340,  ΔR2 =.000, ΔF=.115, p=.734) 
Baseline depression/anxiety, age, 
disease severity, type of surgery 
14 Lam et al. (2013) Bivariate analyses not reported Four coping-related factors including negative cancer-related rumination differentiated 
depression (χ2(8)=132.83, p<.001, R2=.52) and anxiety (χ2(12)=107.00, p<.001, R2=.45) 
trajectories. T1 rumination greater in ‘High-stable/high-recovering’ (OR=1.38 (95% CI=1.18-1.61), 
p<.001) and ‘Recovering’ (OR =1.15 (95% CI=1.03-1.30), p=.017) trajectories compared to low-
depression referent group. T1 rumination greater in ‘High-stable’ (OR =1.22 (95% CI=1.06-1.39), 
p=.005) and ‘Recovering’ (OR = 1.18 (95% CI=1.04-1.34), p=.012), but not ‘Intermediate’, 
trajectories compared to low-anxiety referent group. 
Radiation therapy and occupational 
status (depression model only) 
15 Thomsen et al. (2013) T1 rumination correlates with T2 depression (r=.32, 
p<.05.); T1 depression correlates with T2 rumination 
(r=.37, p<.05.) 
T1 rumination does not predict T2 depression (β=.07, ns) Age, baseline depression 
16 Couper et al. (2010) Bivariate analyses not reported T1 anxious preoccupation does not predict T2 depression (early β=NR, ns; advanced β=.15, ns) 
T1 anxious preoccupation does not predict T2 anxiety in early (β=NR, ns), but does predict 
anxiety in late prostate cancer (β=.21, p<.001) 
Baseline depression, health-related 
quality of life 
17 Lehto & Cimprich (2009)b Worry at T1 correlates with state anxiety at T2 (r=.34, 
p=.027)  
Multivariable analyses not reported None 
18 Lampic et al. (1994) T2 anxious preoccupation correlates with T3 anxiety 
(r=.31, p<.01) 
Multivariable analyses not reported None 
19 Vollmer et al. (2011)a T1 preoccupation with death correlates with T2 
depression (r=.37, p=.013) and anxiety (r=.38, p=.012); T1 
depression (r=.42, p=.009) and anxiety (r=.44, p=.006) 
correlates with T2 preoccupation with death 
T1 preoccupation with death does not predict T2 depression (ΔR2=.004, ΔF=.301, p=.586) or T2 
anxiety (ΔR2=.010, ΔF=.670, p=.418) 
T1 depression (ΔR2=.002, ΔF=.114, p=.738) and T1 anxiety (ΔR2<.000, ΔF=.021, p=.887) does not 
predict T2 preoccupation with death (after controlling for age, sex, and T1 preoccupation with 
death)   
Age, sex, baseline depression (or 
anxiety as appropriate) 
20 Kraaij et al. (2008) T1 rumination correlates with T2 depression (r=.29, 
p<.001); T1 catastrophizing correlates with T2 depression 
(r=.31, p<.001) 
T1 rumination does not predict T2 depressive symptoms (test statistics not reported) 
T1 catastrophizing predicts increased depressive symptoms at T2 (β=.26, p<.05) 
Sex, wish to have children 
21 Kraaij et al. (2010) T1 rumination / catastrophizing correlates with 
depression (r=.37, p<.001) and anxiety (r=.40, p<.001) at 
T2 
T1 rumination/catastrophizing predicts T2 depression (β=.26, p<.05) and T2 anxiety (β=.24, 
p<.05) 
Sex, number of children, time since 
treatment, success of treatment 
22 Nieto et al. (2012) Change (T2-T1) in catastrophizing correlates with change 
in psychological functioning (r=.25, p<.01) 
Change (T2-T1) in catastrophizing does not predict change in psychological functioning (β=.18, 
ns) 
Pain intensity 
23 Jensen et al. (2006) Change (T2-T1) in catastrophizing correlates with change 
in depression (r=.49, p<.001) 
No relevant multivariable analyses reported None 
24 Turner et al. (2004) T1 depression correlates with T2 
catastrophizing/rumination (r=.39, p<.0001) 
Daily catastrophizing/rumination at previous time point does not predict daily negative mood at 
subsequent time point (B=.05, ns) 
Baseline negative mood 
25 Hanley et al. (2004), Jensen et 
al. (2002) 
Bivariate analyses not reported Greater T1 catastrophizing predicts improvements in depression from T1 to T2 (β =.53, p<.001), 
from T1 to T3; β=.46, p<.01) and from T1 to T4; β=.43, p<.05) 
Pain intensity, age, sex 
26 Jensen et al. (2001) Change in catastrophizing correlates with change in Change in catastrophizing predicts change in depression (T1-T2 β =.44, p<.001; T1-T3 β =.48, Baseline pain intensity 
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depression (T1-T2 r=.64, p<.001; T1-T3 r=.61, p<.001; T1-
T4 r=.53, p<.001) 
p<.001; T1-T4 β =.38, p<.001) 
27 Sparkes et al. (2015)b T1 catastrophizing correlates with T2 (r=.55, p<.01) and 
T3 (r=.57, p<.01) depression, and with T2 (r=.51, p<.01) 
and T3 (r=.42, p<.01) anxiety  
T1 catastrophizing correlates with T2 depression (r=.30, p=.026), T3 depression (r=.35, p=.009), 
T2 anxiety (r=.31, p=.02) but not T3 anxiety (r=.21, p=.119) 
Age, gender, baseline depression 
28 Mehlsen et al. (2015)b Bivariate analyses not reported T1 catastrophizing correlated with T2 (r=.23, p=.018) and T3 (r=.24, p=.014) depression, and with 
T2 (r=.24, p=.015) and T3 (r=.31, p=.001) anxiety 
Age, gender, baseline depression 
29 Bourgault et al. (2015)b T1 catastrophizing correlates with T2 (r=.27, p=.0002) 
and T3 (r=.29, p=.0002) depression 
T1 catastrophizing does not predict T2 (β=.35, p=.3562) or T3 (β=-.04, p=. 9231) depression Age, gender, baseline depression, 
treatment arm 
30 Rzewuska et al. (2015) Bivariate analyses not reported T1 catastrophizing differentiated depression- and anxiety-related trajectories over 12 months. 
T1 catastrophizing greater in ‘persistent depression’ group compared to ‘no depression’ referent 
group (adj. OR=3.20 (95% CI=1.53-6.66)). No significant difference between ‘depression 
symptom recovery’ group and ‘no depression’ referent group. 
T1 catastrophizing greater in ‘persistent anxiety’ (adj. OR=8.75 (95% CI=3.66-20.89)) and 
‘transient anxiety’ (adj. OR=4.09 (95% CI=1.38-12.13)) groups compared to ‘no anxiety’ referent 
group. 
Age (depression model only), gender, 
baseline depression/anxiety, coping 
strategies, emotional support, pain-
related variables 
aBased on additional data provided by the authors  
bBased on additional analyses provided by the authors 
Abbreviations: SES=socioeconomic status, T1 = time 1 (baseline), T2 = time 2 (follow-up), T3 = time 3 (follow-up), T4 = time 4 (follow-up), T5 = time 5 (follow-up), T6 = time 6 (follow-up), NR=not reported
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Long term conditions 
Studies reporting multivariable associations were grouped according to LTC (see 
Appendix C; supplementary material).  
In heart disease and chronic pain the majority of studies reported significant 
associations between perseverative negative thinking and depression, anxiety or emotional 
distress. In rheumatoid arthritis and infertility there was mixed evidence of an association 
between perseverative negative thinking and depression, anxiety or emotional distress. The 
majority of studies in cancer patients did not find an association between perseverative 
negative thinking and depression, anxiety or emotional distress. In one small study there 
was no evidence of an association between perseverative negative thinking and depression, 
anxiety or emotional distress in patients with muscular dystrophy. 
 
Physical outcomes 
Associations between perseverative negative thinking and physical outcomes (such 
as health-related quality of life, functional limitations, pain intensity and pain interference) 
were reported in 9 studies[52, 59-63, 68, 69, 71, 72]. Four studies found evidence of an 
association, 1 study found mixed evidence, and 4 studies found no evidence of an 
association. Rumination was not related to subsequent quality of life or functional disability. 
Catastrophizing was associated with impairments in physical outcomes, improvements in 
physical outcomes, and in some studies was not associated with physical outcomes.  
 
Reporting bias 
23 studies reported the results of bivariate analyses, and of those multivariable 
analyses were also available for 19 studies. Significant bivariate associations were found in 
89% of the 19 studies for which both types of analyses were available, and ranged between 
r=.23 to r=.73. In the 4 studies for which multivariable findings were not available, 
significant bivariate associations were found less frequently (75% of the studies) and the 
range of effect sizes was smaller (r=.31 to r=.49). This hints at a possible bias toward 
reporting multivariable analyses where significant or large associations were most likely to 
be found, although this suggestion is based on only 4 observations. 
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Risk of bias 
Component and global risk of bias ratings for each study are presented in Table 3. 
Based on global ratings, 23 of the included studies were moderate quality and 7 were weak 
quality. Studies with overall moderate ratings were not all equivalent; 5 studies were 
assigned 3 strong component ratings and these were comparatively good quality[52, 55, 75, 
76, 79] with particular strengths in retention of participants at follow-up (>80%), control for 
appropriate confounders, and reliability/validity of data collection methods. Four of these 5 
studies found significant associations between perseverative negative thinking and 
subsequent depression, anxiety or emotional distress after controlling for relevant 
confounders including baseline depression. 
Among the overall weak quality studies, selection bias and retention of participants 
were identified as areas of concern. In multivariable analyses associations between 
perseverative negative thinking and subsequent depression, anxiety or emotional distress 
were found less often in studies of weak methodological quality.  
In heart disease and chronic pain, studies which did not find an effect had small 
sample sizes at follow-up [73, 77], or used unusual methods to collect or analyse data (time 
series data and use of change scores[72]).  
In rheumatoid arthritis, where evidence of an association was weak, studies tended 
to be of weak quality due to low sample sizes, high numbers of withdrawals at follow-up, 
and limited reliability of measures. Similarly, there was weak evidence of an association in 
people experiencing infertility and these studies tended to be weak quality due to use of 
self-selected samples and high numbers of withdrawals.  
Studies in cancer patients, in whom evidence of an association between 
perseverative negative thinking and depression, anxiety or emotional distress was weak, 
recruited quite heterogeneous participants and, unlike other studies, focussed on ‘anxious 
preoccupation’ and ‘preoccupation with death’, which may have influenced findings. 
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Table 3: Risk of bias/quality assessment 
ID Authors and date 
 
Selection bias Designa Confounding Blindingb Data collection Withdrawals Global rating 
1 Denton et al. (2012, 2011) 2 2 1 2 1 1 2 
2 Garnefski & Kraaij (2010) 2 2 2 2 1 3 2 
3 Vogele et al. (2012) 3 2 2 2 1 3 3 
4 Baker (2014) 2 2 1 2 1 1 2 
5 Xiao et al. (2011) 1 2 2 2 1 1 2 
6 Keefe et al. (1989) 3 2 1 2 1 3 3 
7 Sturgeon & Zautra (2013) 3 2 2 2 3 3 3 
8 Schiaffano & Revenson (1995) 2 2 3 2 3 2 3 
9 Sharpe et al. (2001) 2 2 2 2 1 3 2 
10 Wang et al. (2014) 2 2 1 2 1 1 2 
11 Andreu et al. (2012) 2 2 3 2 1 1 2 
12 Ferrero et al. (1994) 2 2 2 2 1 1 2 
13 Groarke et al.(2013) 3 2 1 2 1 2 2 
14 Lam et al. (2013) 2 2 3 2 1 1 2 
15 Thomsen et al. (2013) 2 2 2 2 1 1 2 
16 Couper et al. (2010) 2 2 2 2 1 2 2 
17 Lehto & Cimprich (2009) 2 2 3 2 1 1 2 
18 Lampic et al. (1994) 2 2 3 2 1 2 2 
19 Vollmer et al. (2011) 2 2 1 2 1 3 2 
20 Kraaij et al. (2008) 3 2 2 2 1 3 3 
21 Kraaij et al. (2010) 3 2 2 2 1 3 3 
22 Nieto et al. (2012) 3 2 3 2 1 3 3 
23 Jensen et al. (2006) 2 2 3 2 1 1 2 
24 Turner et al. (2004) 3 2 2 2 1 1 2 
25 Hanley et al. (2004), Jensen et 
al. (2002) 
2 2 2c 2 1 2 2 
26 Jensen et al. (2001) 2 2 3 2 1 2 2 
27 Sparkes et al. (2015) 2 2 1 2 1 2 2 
28 Mehlsen et al. (2015) 2 2 1 2 1 1 2 
29 Bourgault et al. (2015) 3 2 1 2 1 2 2 
30 Rzewuska et al. (2015) 2 2 3 2 1 2 2 
1=strong, 2=moderate and 3=weak 
aAll studies were rated as moderate quality on the study design component. There was 1 RCT[77] which would have qualified for a strong quality rating, however because the data extracted for this review related to 
changes in the whole cohort over several assessment times this study was treated as a cohort study for the purpose of quality assessment for this component 
bThe blinding component was modified to be more suitable for the included study designs, although it remained difficult to assign ratings for this component and all studies were rated as moderate quality as it was 
not possible to tell if the researcher was exposed to information about the participant that could lead to bias, or if the participants were aware of the research question 
cJensen et al. = 3 (no control for confounders at 6 month follow-up), and Hanley et al. = 2 (control for some confounders at 12 and 24 months follow-up)  
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Discussion 
We conducted a systematic review to clarify among people with LTCs the temporal 
relationship between perseverative negative thinking, on the one hand, and depression, 
anxiety or emotional distress, on the other, and to determine the strength of the 
prospective associations. Findings were limited mainly to the association of rumination 
and/or catastrophizing with subsequent depression. The majority of uncontrolled studies 
showed an association between measures of perseverative negative thinking and 
subsequent depression, anxiety or emotional distress. Studies controlling for the effects of 
covariates, including depression at baseline, using multivariable analysis showed more 
mixed results, though the majority of studies (15 / 25 studies) still supported a significant 
association, with effects being small in magnitude.  
Strongest associations were observed in studies measuring catastrophizing. The 
strength of association between perseverative negative thinking and subsequent 
depression, anxiety or emotional distress appeared to vary across studies of different LTCs, 
with greatest effects seen in people with heart disease and chronic pain. Whilst degrees of 
perseverative negative thinking and of depression, anxiety or emotional distress might 
reasonably be expected to vary across long term conditions, it isn’t immediately obvious 
why the relationship between such thinking and depression, anxiety or emotional distress 
should vary between LTCs. It is possible that some of the variability between LTCs could be 
due to the use of different perseverative negative thinking constructs in the different 
samples (e.g. studies in pain conditions tended to measure pain catastrophizing, studies in 
cancer patients tended to measure anxious preoccupation and preoccupation with death). 
The different measures are likely to reflect different dimensions of repetitive thinking, 
suggesting that some dimensions are important predictors of depression, anxiety or 
emotional distress while others are not. 
Contrary to expectation, one study found that greater catastrophizing at baseline 
predicted improvements in depression from baseline to 6, 12 and 24 month follow-ups. 
Baseline catastrophizing was concurrently associated with higher levels of depression in this 
study, as might be expected. Since the authors did not control for the effects of depression 
at baseline, this counter-intuitive finding may have arisen because individuals with high 
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levels of catastrophizing (and therefore also depression) at baseline had more potential for 
improvement in depression during follow-up.  
Too few studies investigated the association of baseline depression, anxiety or 
emotional distress with subsequent perseverative negative thinking to be able to draw firm 
conclusions about the reverse association. Among the studies identified, few included 
measures of physical health outcome, and findings from those studies were very mixed.  
The quality of studies identified was highly variable, with no “strong” studies being 
identified. Quality was most frequently low due to studies failing to control adequately for 
potential confounding variables or due to high numbers of participants dropping-out, which 
reduced the generalisability of findings. Interestingly, we found significant associations least 
frequently in the studies rated as weak compared to studies rated moderate, suggesting 
that poor control for confounders did not increase the likelihood of an association being 
found in studies identified for this review. A number of studies had small sample sizes and 
the majority of such studies failed to find an association between perseverative negative 
thinking and subsequent depression, anxiety or emotional distress. There was significant 
variation in study quality across LTCs.  
This systematic review is the first to investigate the prospective association of 
perseverative negative thinking with subsequent depression, anxiety or emotional distress 
specifically in people with LTCs. The main strengths of this review are that it adhered to 
established guidelines[44, 45] to ensure rigorous methods were used. A comprehensive 
search strategy was used, combined with supplementary backward and forward citation 
searches of included papers. In addition, we are confident that our strategy of hand-
searching records for LTCs ensured that all studies containing relevant samples were 
identified. We did not apply a priori restrictions to the definition of LTCs. The group of 
conditions identified was heterogeneous and this may have contributed to the 
heterogeneity of findings although it is unclear whether variations in study quality across 
different LTC groups may explain this observation. Eligibility screening, data extraction and 
quality assessment were undertaken by two reviewers to minimise bias and maximise 
reliability. Since we were interested in clarifying the temporal relationships between 
perseverative negative thinking and depression, anxiety or emotional distress, we included 
studies investigating prospective associations in either direction. 
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There are some limitations of this systematic review. First, the majority of this review 
is based on published journal articles so the conclusions are vulnerable to the effects of 
publication bias. We did find some suggestion of publication bias, in that studies presenting 
multivariable findings were more likely to have larger bivariate associations, compared to 
those that did not present multivariable findings. Second, we did not perform meta-analysis 
due to the multitude of measures of both perseverative negative thinking and depression, 
anxiety or emotional distress, and also due to heterogeneity in research methods used 
(including variables controlled for, and study quality). Rather, we synthesised our findings 
using vote counts, which is a crude method of synthesis and does not take account of the 
effect sizes or precision of individual studies. Conducting a meta-analysis using only studies 
presenting bivariate analyses would have allowed us to synthesize a subset of more 
comparable studies. However this would have lead to an overestimate of the associations 
since important confounding variables would not have been controlled for. Third, we 
presented findings for associations of perseverative negative thinking with physical health 
outcomes, such as quality of life, where these were presented within the eligible papers. 
However, we acknowledge that our searches were not designed to identify all such studies, 
since investigating the impact on physical health outcomes was not a primary objective of 
our review. There are likely to be other studies relevant to this objective that were not 
identified by our search processes. As a consequence, no firm conclusion on the association 
of perseverative negative affect and physical health outcomes can be drawn from our 
review. 
We interpret the findings of our review as indicating that perseverative negative 
thinking (particularly catastrophizing) is prospectively associated with a range of subsequent 
negative affective states among people with LTCs, even after controlling for important 
covariates such as depression at baseline. Evidence of perseverative negative thinking 
predicting subsequent adverse medical outcomes in the studies identified was too mixed to 
enable firm conclusions. There was no convincing evidence that depression, anxiety or 
emotional distress predicted subsequent perseverative negative thinking, particularly after 
controlling for covariates.  
Our findings are consistent with perseverative negative thinking causing depression, 
anxiety or emotional distress among people with LTCs, but current evidence falls short of 
proving causation. Perseverative negative thinking has been described within the context of 
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a number of theoretical models, and these models offer either overt or implicit suggestions 
as to how perseverative negative thinking could lead to depression. The Response Styles 
Theory[21] posits that perseverative negative thinking (in particular depressive rumination) 
could lead to depression via several mechanisms including focusing attention on and 
elaboration of negative thoughts, interfering with problem solving, reducing motivation to 
engage in constructive behaviours, and eroding social support. On the other hand control 
theory approaches[83, 84] emphasize managing discrepancies between actual and desired 
states. This suggests that perseverative negative thinking could lead to depression when it is 
not possible to reduce such discrepancies (either by making progress toward, or changing, 
the desired state) because the discrepancy focuses attention on the unresolved issue and 
makes it more salient. These models of perseverative negative thinking were not developed 
specifically with people with chronic physical illnesses in mind, and previous research has 
tended to focus on otherwise healthy individuals, and so it is unclear to what extent these 
models apply to people with LTCs. 
There did not appear to be any variation in findings based on whether follow-up took 
place before or after the median follow-up time of 6 months. However, closer inspection 
suggested that effects were identified more often in studies with intermediate length 
follow-up. This variation with length of follow-up could be due to significant changes in the 
status of the LTC or due to fluctuations in levels of perseverative negative thinking over 
time. Future studies should carefully consider the length of follow-up or risk missing a true 
association. It seems most likely that a follow-up between 1 and 12 months would be most 
appropriate. 
The results of this review are consistent with the findings of previous narrative ([20, 
23, 25]) and systematic ([22, 24]) reviews focussed on physically healthy individuals. Similar 
to ours, these previous reviews noted that, compared to the results of cross-sectional 
studies, the findings from prospective research are more mixed although the majority of 
such studies did support an association. In these previous reviews, moderators of the 
association between perseverative negative thinking and subsequent symptoms of 
depression and anxiety or negative affect that relate to characteristics of the population 
(e.g. gender, psychopathology) and to aspects of repetitive thinking itself (e.g. valence, 
content) have been suggested to explain some of the variability in findings.  
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Further high quality research is required to clarify the association of perseverative 
negative thinking, on the one hand, with psychological and other medical outcomes such as 
quality of life, morbidity and mortality, on the other. Experimental studies in which 
perseverative negative thinking is induced or interrupted, with effects on depression, 
anxiety or emotional distress monitored, would provide good evidence of a causal 
association and indicate that perseverative negative thinking is a relevant target for 
treatment of depression and other psychological outcomes in people with LTCs. Future 
prospective and experimental research should investigate differences of associations of 
perseverative negative thinking with  depression, anxiety or emotional distress in groups of 
individuals with different LTCs. In addition, attempts should be made to clarify mechanisms 
that might explain how and why perseverative negative thinking contributes to depression, 
anxiety and emotional distress. A number of possible mechanisms have been suggested in 
the research literature, including via a reduction in social support, impairment of problem 
solving, reduced motivation to perform positive instrumental behaviours and increased 
negative thinking[20, 21]. These mechanisms could also provide potential targets for 
intervention aimed at improving depression and also physical health outcomes. 
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Supplementary material 
Appendix A: Search strategy 
The same search strategy was used with alterations as appropriate for each database. 
 
1 depression.ti,ab,sh. 
2 depressive disorder.ti,ab,sh. 
3 anxiety.ti,ab,sh. 
4 anxiety disorder*.ti,ab. or anxiety disorders.sh. 
5 stress, psychological.sh. 
6 psychological distress.ti,ab. 
7 emotional distress.ti,ab. 
8 1 or 2 or 3 or 4 or 5 or 6 or 7 
9 perseverative.ti,ab. and cognition.ti,ab,sh. 
10 (perseverative and cognitive and processes).ti,ab. 
11 perseverative.ti,ab. and thinking.ti,ab,sh. 
12 (perseverative and thought).ti,ab. 
13 repetitive.ti,ab. and thinking.ti,ab,sh. 
14 (repetitive and thought).ti,ab. 
15 (worry* or worrie* or worrisome).ti,ab. 
16 ruminat*.ti,ab. 
17 response styles theory.ti,ab. 
18 brooding.ti,ab. 
19 preoccupation.ti,ab. 
20 (self focus or self focused attention).ti,ab. 
21 emotion regulation.ti,ab. 
22 coping strateg*.ti,ab. 
23 coping style.ti,ab. 
24 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 
25 longitudinal studies.sh. or longitudinal study.ti,ab. 
26 prospective studies.sh. or prospective study.ti,ab. 
27 followup studies.sh. or follow up.ti,ab. 
28 baseline.ti,ab. 
29 experience sampling.ti,ab. 
30 time series.ti,ab. 
31 induction*.ti,ab. 
32 25 or 26 or 27 or 28 or 29 or 30 or 31 
33 8 and 24 and 32 
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Appendix B: Additional methodological details 
 
Study selection 
Eligibility screening took place in two stages. First, titles and abstracts were 
independently screened by two reviewers (LT, SH) to identify potentially relevant studies. 
Studies that did not meet specific inclusion/exclusion criteria at this stage were rejected, 
and disagreements between the two reviewers were resolved by discussion, with the 
involvement of a third reviewer (CD) where agreement could not be reached. Next, full text 
copies of all remaining records were obtained and independently assessed by two reviewers 
(LT, SW). Again, studies that did not meet specific inclusion/exclusion criteria were rejected, 
and the reason for rejection was recorded. Multiple reports of the same study were 
combined and counted only once. 
 
Data extraction 
Data from all included studies was extracted independently by two reviewers (LT, 
SW) into a standardised data extraction form that was piloted on three studies, with 
adaptations made in a stepwise fashion. Discrepancies were resolved by discussion. Data 
extracted included details of study design, sample characteristics and demographics, 
measures of perseverative negative thinking and psychological outcomes (i.e. depression, 
anxiety or emotional distress), frequency and timing of assessments, measures of physical 
health/medical outcomes, statistical methods including variables controlled for, outcomes 
of statistical analyses, and information relating to quality assessment. Authors of included 
studies were contacted to provide missing or additional data where necessary.   
 
Quality assessment/risk of bias 
The Effective Public Health Practice Project (EPHPP) Quality Assessment Tool[49] was 
used to assess risk of bias within each study. Ratings were made for six components: 
selection bias, study design, confounders, blinding, data collection methods, and 
withdrawals. Each component was rated strong, moderate or weak. Component ratings 
were combined into a global score of strong where there were at least 4 strong and no weak 
component ratings, moderate where there was 1 weak component rating, and weak where 
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there were two or more weak component ratings. Quality was independently evaluated by 
two reviewers (LT, SW) at outcome level. 
We modified two of the risk of bias components in light of the design of the included 
studies. First, the confounders component is intended to evaluate whether there were 
important differences between study groups prior to an intervention. However, as there 
were no group comparisons in the included studies (or data related to group comparisons 
was not extracted because it was not relevant) we evaluated ‘Were any relevant 
confounders controlled for, in the design of the study or in the analysis?’. Relevant 
confounders were defined as age, sex and baseline depression as these are all known to be 
associated with depression. Studies were rated strong where all three of these confounders 
were controlled for, moderate where some of these confounders were controlled for, and 
weak where no confounders (or others not listed) were controlled for. Second, the blinding 
component is intended to evaluate whether outcome assessors were aware of the 
intervention or exposure status of participants. However, as participants were not allocated 
to groups or conditions in the included studies (or if they were, data relating to groups or 
conditions was not extracted because it was not relevant) the blinding component 
evaluated: (a) ‘was the researcher exposed to information about the participant that could 
lead to bias?’ For example, was the researcher aware of participants’ previous responses 
when administering questionnaires, or did researchers have access to participant data from 
previous or other assessments when scoring questionnaires, and (b) ‘was the participant 
aware of the research question?’. 
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Appendix C: Vote count of studies that report an association between perseverative negative thinking and  psychological outcomes 
(multivariable findings)  
 
 
 
 
Depression Anxiety 
Negative 
affect Distress 
Psychological 
functioning  
Negative 
mood 
Heart disease Rumination 1 3 4 5      
Catastrophizing 5      
Rumination/catastrophizing 2      
RA Rumination 8R      
Catastrophizing 6 7 9 9 7    
Cancer Anxious preoccupation 13 16 13 16 13 12   
Preoccupation with death 19 19R 19 19R     
Catastrophizing 10      
Rumination 10 14 15 14     
Infertility Catastrophizing 20      
Rumination 20      
Rumination/catastrophizing 21 21     
Muscular 
dystrophy/Cerebral 
palsy 
Catastrophizing     22C  
Pain-related 
conditions 
Catastrophizing 25CE 26C 27 
28 29 30 
27 28 
30 
    
Rumination/catastrophizing      24 
Red=No association Green=Association Black=Mixed evidence  
Numbers refer to study ID (see Tables 1 to 3) 
Empty cells represent no relevant results 
R=reverse relationship (i.e. T1 negative affect associated with T2 perseverative negative thinking)  
C=change scores (i.e. change in perseverative negative thinking associated with change in negative affect)  
E=association not in expected direction 
